Ken Davis

President and CEO, Mount Sinai Health System (Festival Underwriter); Trustee, The Aspen Institute

Ken Davis is CEO and president of Mount Sinai Health System. He is a leader in the move away from fee-for-service medicine to population health, keeping more patients healthy and out of the hospital. As a neurobiologist, his Alzheimer’s disease research led the FDA to approve three of the first four treatment drugs on the market. An elected member of the Institute of Medicine and author of more than 575 scientific articles, Davis is a highly cited researcher in the field of brain diseases. His numerous honors include the George H. W. Bush Lifetime of Leadership Award from Yale University. He is a trustee of the Aspen Institute.

Videos/Audio of Ken Davis

Academic medicine remains on the cutting-edge of healthcare, dedicating vast resources to education, research, and... See more
How do we bend the cost curve and provide top health care at the same time? See more
Advances in genomics, personalized medicine, and new therapeutics frame part of the picture. So do changes in health... See more
Why are rapidly evolving scientific discoveries not being translated into treatments for the country's most pressing... See more

Pages